The Food and Drug Administration is requesting that CAR-T cell therapies now come with a Boxed Warning about secondary malignancies that have been reported in patients who undergo these treatments.
Vanda Pharmaceuticals Announces The Publication Of Efficacy And Safety Of Iloperidone In Bipolar Mania: A Double-Blind, Placebo-Controlled Study In Th menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
WASHINGTON, Jan. 17, 2024 /PRNewswire/ Vanda Pharmaceuticals Inc. today announced the publication of an article titled Efficacy and Safety of Iloperidone in Bipolar Mania: A Double-Blind,.
/PRNewswire/ Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Efficacy and Safety of Iloperidone in.
New VOYAGER PAD Analyses Reinforce Benefit of XARELTO® (rivaroxaban) Plus Aspirin Across High-Risk and Complex Patient Populations with Peripheral Artery Disease (PAD) streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.